Sentio Labs, the Greek branch of Feel Therapeutics Inc., is the company where the entirety of the company’s research and development (R&D) activities are conducted. Feel Therapeutics is a San Francisco-based start-up, which develops Biomarkers and Digital Therapeutics to bring objective data and measurement to change the way we diagnose, manage, and care for mental health.
Sentio has received multiple awards including the “Insurance Shaper of the Year” award by EXECinsurtech and 2016 & 2017 “Transformative Technology Company” recognition by Transtech. The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and partners with large Pharmaceuticals to advance their clinical development, RWE, and commercialization strategies. completed its first funding round in December 2017 having raised a total of $1.8 million in seed funding from Anthemis Exponential Ventures, SOSV, Make in LA, and angel investors. Feel consists of 3 parts: the Wristband, Proprietary Algorithms, and the Mobile Application. The wristband has integrated bio-sensors that monitor a variety of physiological signals throughout the day, while in the background, proprietary algorithms analyze these signals to recognize the wearer’s emotions. The mobile application receives the data from the wristband and monitors the emotions of the user, providing personalized recommendations as well as real-time coaching and intervention based on the principles of Cognitive Behavioral Therapy.
“Sentio Labs PC – G.E.MI.# 147366201000″